Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.71 |
| ▸ | EGLN1 | Q9GZT9 | 6/20 | 0.64 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.64 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.64 |
| ▸ | PHF8 | Q9UPP1 | 7/20 | 0.60 |
| ▸ | KDM2A | Q9Y2K7 | 7/20 | 0.60 |
| ▸ | KDM5C | P41229 | 4/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.60 |
| ▸ | KDM6B | O15054 | 3/20 | 0.60 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.47 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.47 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Levulinic Acid SCHEMBL30530258 | 1.00 | — | — | |
| Levulinic Acid SCHEMBL27931545 | 1.00 | LMNA (1.00) | LMNASLC15A2ALDH1A1EGLN1ALKBH5 | |
| Levulinic Acid SCHEMBL20868 | 1.00 | — | — | |
| Levulinic Acid SCHEMBL2577171 | 0.97 | — | — | |
| Levulinic Acid SCHEMBL21815654 | 0.97 | — | — | |
| Levulinic Acid SCHEMBL8063365 | 0.97 | LMNA (0.93) | LMNASLC15A2ALDH1A1EGLN1ALKBH5 | |
| Levulinic Acid SCHEMBL21815797 | 0.97 | — | — | |
| Levulinic Acid SCHEMBL21815633 | 0.97 | — | — | |
| Levulinic Acid SCHEMBL10791504 | 0.97 | — | — | |
| Levulinic Acid SCHEMBL8061193 | 0.97 | LMNA (0.93) | LMNASLC15A2ALDH1A1EGLN1ALKBH5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 480 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028539-A1 | COMPOSITIONS FOR PRODUCTION OF OLEFINS, TERPENES, AROMATICS AND CYCLOALIPHATICS AND METHODS THEREFOR, AND PRODUCTS THEREFROM | VISOLIS INC (US) | 2026-01-29 | — | — | US | claimed |
| EP-3063164-B1 | SYNTHETIC ROUTE TO 2'-DEOXY-2',2'-DIFLUOROTETRAHYDROURIDINES | OTSUKA PHARMA CO LTD (JP) | 2018-12-05 | — | — | EP | claimed |
| US-20120094836-A1 | Biocide Compositions (III) | COGNIS IP MANAGEMENT GMBH (DE) | 2012-04-19 | — | — | US | claimed |
| WO-2011026580-A2 | BIOCIDE COMPOSITIONS (IV) | COGNIS IP MANAGEMENT GMBH (DE) | 2011-03-10 | — | — | WO | claimed |
| EP-2292092-A1 | Biocide compositions comprising esters of ketocarboxylic acids | Cognis IP Management GmbH (DE) | 2011-03-09 | — | — | EP | claimed |
| EP-2269451-A1 | Biocide compositions (III) | Cognis IP Management GmbH (DE) | 2011-01-05 | — | — | EP | claimed |
| US-20260092130-A1 | PROCESS FOR SYNTHESIZING POLYMER COMPOSITIONS FROM STARTING MATERIALS COMPRISING A DOUBLE BOND | VISOLIS INC (US) | 2026-04-02 | — | — | US | disclosed |
| US-20260092228-A1 | COMPOSITIONS FOR FUEL BLENDING MADE BY A SUSTAINABLE PROCESS, AND SUSTAINABLE FUEL COMPOSITIONS THEREFROM | VISOLIS INC (US) | 2026-04-02 | — | — | US | disclosed |
| US-20260092023-A1 | PROCESS SYNTHESIZING SUSTAINABLE AVIATION FUEL COMPOSITIONS | VISOLIS INC (US) | 2026-04-02 | — | — | US | disclosed |
| US-20260055330-A1 | HIGH ENERGY DENSITY ROCKET FUEL COMPOSITIONS | VISOLIS INC (US) | 2026-02-26 | — | — | US | disclosed |
| WO-2026022791-A1 | HIGH ENERGY DENSITY ROCKET FUEL COMPOSITIONS | Visolis, Inc. (US) | 2026-01-29 | — | — | WO | disclosed |
| US-20260028540-A1 | PROCESS SYNTHESIZING SUSTAINABLE AVIATION FUEL COMPOSITIONS FROM STARTING MATERIALS COMPRISING A DOUBLE BOND | VISOLIS INC (US) | 2026-01-29 | — | — | US | disclosed |
| US-20260028545-A1 | SUSTAINABLE AVIATION FUEL COMPOSITIONS | VISOLIS INC (US) | 2026-01-29 | — | — | US | disclosed |
| US-20010051632-A1 | Phenyl-substituted indolizines and tetrahydroindolizines | ORTHO MCNEIL PHARMACEUTICAL, INC. | 2001-12-13 | — | — | US | disclosed |
| US-20010044439-A1 | Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as H3 antagonists | ORTHO MCNEIL PHARMACEUTICAL, INC. | 2001-11-22 | — | — | US | disclosed |
| WO-2001074815-A2 | PHENYL-SUBSTITUTED IMIDAZOPYRIDINES | ORTHO MCNEIL PHARMACEUTICAL, INC. (US) | 2001-10-11 | — | — | WO | disclosed |
| WO-2001074814-A1 | PHENYL-SUBSTITUTED INDOLIZINE DERIVATIVES AND THEIR USE AS HISTAMINE H3 LIGANDS | ORTHO MCNEIL PHARMACEUTICAL, INC. (US) | 2001-10-11 | — | — | WO | disclosed |
| WO-2001074813-A2 | METHOD FOR USING 2- OR 3-ARYL SUBSTITUTED IMIDAZO[1,2-a] PYRIDINES AS H3 ANTAGONISTS | ORTHO MCNEIL PHARMACEUTICAL, INC. (US) | 2001-10-11 | — | — | WO | disclosed |
| WO-2001074773-A2 | PHENYL-SUBSTITUTED INDOLES AS HISTAMINE H3-RECEPTOR ANTAGONISTS | ORTHO MCNEIL PHARMACEUTICAL, INC. (US) | 2001-10-11 | — | — | WO | disclosed |
| WO-2001074810-A2 | METHOD FOR USING 2-ARYLOXYALKYLAMINOBENZOXAZOLES AND 2-ARYLOXYALKYLAMINOBENZOTHIAZOLES AS H3 ANTAGONISTS | ORTHO MCNEIL PHARMACEUTICAL, INC. (US) | 2001-10-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092228-A1 | COMPOSITIONS FOR FUEL BLENDING MADE BY A SUSTAINABLE PROCESS, AND SUSTAINABLE FUEL COMPOSITIONS THEREFROM | CYP4F12, CYP4F11, CYP4F8 | LMNA 2643/4885SLC15A2 2596/4885ALDH1A1 700/4885 |
| US-20260028540-A1 | PROCESS SYNTHESIZING SUSTAINABLE AVIATION FUEL COMPOSITIONS FROM STARTING MATERIALS COMPRISING A DOUBLE BOND | AHR, COASY, YAP1 | LMNA 1431/4885SLC15A2 2187/4885ALDH1A1 741/4885 |
| US-20260092023-A1 | PROCESS SYNTHESIZING SUSTAINABLE AVIATION FUEL COMPOSITIONS | CYP4A11, HMGCR, FADS1 | LMNA 1499/4885SLC15A2 2255/4885ALDH1A1 569/4885 |
| US-20010044439-A1 | Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as H3 antagonists | HRH3, HRH4, HRH2 | LMNA 3594/4885SLC15A2 3995/4885ALDH1A1 1270/4885 |
| US-20260055330-A1 | HIGH ENERGY DENSITY ROCKET FUEL COMPOSITIONS | HMGCR, CYP46A1, GGPS1 | LMNA 1842/4885SLC15A2 3145/4885ALDH1A1 1657/4885 |
| US-20260092130-A1 | PROCESS FOR SYNTHESIZING POLYMER COMPOSITIONS FROM STARTING MATERIALS COMPRISING A DOUBLE BOND | SAMM50, MAX, HSF1 | LMNA 2269/4885SLC15A2 3436/4885ALDH1A1 1681/4885 |
| US-20260028539-A1 | COMPOSITIONS FOR PRODUCTION OF OLEFINS, TERPENES, AROMATICS AND CYCLOALIPHATICS AND METHODS THEREFOR, AND PRODUCTS THEREFROM | CYP4F11, FDFT1, CYP4A11 | LMNA 3663/4885SLC15A2 1068/4885ALDH1A1 413/4885 |
| US-20010051632-A1 | Phenyl-substituted indolizines and tetrahydroindolizines | TPH2, TPH1, IDO2 | LMNA 2489/4885SLC15A2 1992/4885ALDH1A1 967/4885 |
| US-20260028545-A1 | SUSTAINABLE AVIATION FUEL COMPOSITIONS | CYP4F12, CYP4F11, CYP4F8 | LMNA 1546/4885SLC15A2 1906/4885ALDH1A1 694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.